KCR S.A.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2007-09-28
Share capital
506,246.20 PLN
Activity description

ICON plc provides clinical research outsourcing services for biotech and small to mid-sized biopharma companies. It supports programs from early-phase design through market access, and offers consulting, advisory services, and tailored clinical development. The company also focuses on areas such as genomic breakthroughs, first-in-class immunotherapies, and drug development in APAC and China.

Registered address
ul. Prosta 68, 00-838 Warszawa, Poland
Website
Social media
Electronic delivery address
AE:PL-89455-60296-DJADD-26

Financials

Revenue history (in m)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 81 days late). All were audited by a statutory auditor.

  • 2024not filed
  • 202309/07/2024
  • 202212/07/2023
  • 202104/10/2022
  • 202005/08/2021
  • 201915/10/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Top 1.6%
Voivodeship · Mazowieckie2,091 / 142,204
Top 1.5%
Country · Poland6,249 / 496,474
Top 1.3%

Results vs industry

Revenue
This companyUSD 43.60mMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD 489.33kMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 42.03mMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 27.86mMedianUSD 281.58kAverageUSD 8.35m

Offer

Certifications: GMP

Website technology

Website
  • Drupal
Analytics and marketing
  • Google Tag Manager

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 6 marks have expired or were not registered. The first mark was filed in 2013.

MarkNumberClassesStatusProtected until
KCR Z.41999235, 42Expired –
KCR Z.41999335, 42Expired –
KCR KNOWLEDGE / COMMITMENT / RESULTS Z.41999435, 42Expired –
KCR KNOWLEDGE COMMITMENT RESULTS Z.41999535, 42Expired –
KNOWLEDGE COMMITMENT RESULTS KCR Z.41999635, 42Expired –
MarkProtected until
KCR –
KCR –
KCR KNOWLEDGE / COMMITMENT / RESULTS –
KCR KNOWLEDGE COMMITMENT RESULTS –
KNOWLEDGE COMMITMENT RESULTS KCR –

Authorized Representatives

Emer Lyons – Management Board Member
Simon Hollywood – Management Board Member
Simon Holmes – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations of will on behalf of the company independently.

Supervisory board

Diarmaid Cunningham – Supervisory Board Member
Julian Hayes – Supervisory Board Member
James Houlihan – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
Curandus sp. z o.o.
100%

Bank accounts

Registered as a VAT taxpayer on 2001-12-04.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
May 7, 2024Commercial Companies Code notice
Nov 21, 2019Financial statement published
Aug 1, 2018Bankruptcy notice
Nov 17, 2014Bankruptcy notice
Nov 3, 2014Financial statement published

Public aid

No public aid cases recorded in the last 10 years.

European Funds

ProjectEU co-financing
Health-f2-2010-261358/paddington
$1.8M

Competitors

Name
Selvita S.A.
Iqvia Rds Poland sp. z o.o.
PPD Poland sp. z o.o.
Eurofins Polska sp. z o.o.
Pratia S.A.
Sieć Badawcza Łukasiewicz - Instytut Chemii Przemysłowej Imienia Profesora Ignacego Mościckiego Research institute
Narodowy Instytut Leków Research institute
Sieć Badawcza Łukasiewicz - Instytut Przemysłu Organicznego Research institute
Kapadi sp. z o.o.
Biostat sp. z o.o.

Change history

DateEvent
2025-04-28Address change
2025-04-28Switch to PKD 2025
2024-07-18Share capital reduction
2018-05-21Share capital reduction
2015-01-12PKD change

FAQ

Last updated: 2026-03-22